Thiol-reactive bifunctional chelators for the creation of site-selectively modified radioimmunoconjugates with improved stability Journal Article


Authors: Adumeau, P.; Davydova, M.; Zeglis, B. M.
Article Title: Thiol-reactive bifunctional chelators for the creation of site-selectively modified radioimmunoconjugates with improved stability
Abstract: Maleimide-bearing bifunctional chelators have been used extensively for the site-selective bioconjugation and radiolabeling of peptides and proteins. However, bioconjugates obtained using these constructs inevitably suffer from limited stability in vivo, a trait that translates into suboptimal activity concentrations in target tissues and higher uptake levels in healthy, nontarget tissues. To circumvent this issue, phenyloxadiazolyl methylsulfones have previously been reported as alternatives to maleimides for thiol-based ligations, but these constructs have scarcely been used in the field of radiochemistry. In this report, we describe the synthesis of two thiol-reactive bifunctional chelators for 89Zr and 177Lu based on a new, easy-to-make phenyloxadiazolyl methylsulfone reagent, PODS. Radioimmunoconjugates created using these novel bifunctional chelators displayed in vitro stability that was higher than that of their maleimide-derived cousins. More importantly, positron emission tomography imaging in murine models of cancer revealed that a 89Zr-labeled radioimmunoconjugate created using a PODS-bearing bifunctional chelator produced a rate of uptake in nontarget tissues that is significantly lower than that of its analogous maleimide-based counterpart. © 2018 American Chemical Society.
Journal Title: Bioconjugate Chemistry
Volume: 29
Issue: 4
ISSN: 1043-1802
Publisher: American Chemical Society  
Date Published: 2018-04-18
Start Page: 1364
End Page: 1372
Language: English
DOI: 10.1021/acs.bioconjchem.8b00081
PROVIDER: scopus
PUBMED: 29509393
PMCID: PMC6523022
DOI/URL:
Notes: Article -- Export Date: 1 May 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Zeglis
    118 Zeglis